SEC Form 4 · accession 0001596771-18-000072
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shawn Tomasello
Director
Period of report
Jun 1, 2018
Accepted (ET)
Jun 5, 2018 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2018 | A | 3,654 | $0.00 | A | 12,816 | D | |
| Common StockF2,F3 | Jun 5, 2018 | S | 1,680 | $24.2654 | D | 11,136 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of restricted stock were granted in connection with the Issuer's non-employee director compensation program.
- F2The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the vesting of previously granted restricted stock.
- F3The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $24.2101 to $24.46. Upon request by the SEC staff, the Issuer or any securityholder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.